Long-Term Clinical Outcomes of Drug-Coated Balloon Treatment for De Novo Coronary Lesions.
Ae-Young HerBitna KimSoe Hee AhnYong-Whi ParkJung-Rae ChoYoung Hoon JeongEun-Seok ShinPublished in: Yonsei medical journal (2023)
At 5-year follow-up, DCB treatment was significantly associated with reduced incidences of MACE and TVR, compared with DES implantation, for de novo coronary lesions.